Skip to main content

Table 1 Clinical characteristics and METTL3 expression level in Endometriosis

From: METTL3-mediated m6A modification of SIRT1 mRNA inhibits progression of endometriosis by cellular senescence enhancing

Clinicopathological Features

Cases (n)

METTL3 relative expression

p value

r-AFS stage

 I, II

13

2.50 ± 0.33

< 0.001***

 III, IV

17

1.03 ± 0.15

Cyst size (cm)

 < 3

14

2.05 ± 0.26

< 0.001***

 ≥ 3

16

1.33 ± 0.14

DIE

 No

21

1.55 ± 0.33

< 0.01**

 Yes

9

1.94 ± 0.30

Dysmenorrhea

 No symptoms

10

1.74 ± 0.18

0.216

 Moderate

13

1.65 ± 0.17

 Severe

7

1.59 ± 0.14

Age

 ≤ 25

10

1.63 ± 0.19

0.784

 25–35

14

1.69 ± 0.14

 35–45

6

1.67 ± 0.17

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us